我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

血府逐瘀汤对冠心病同型半胱氨酸水平影响的研究(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2014年04期
页码:
51-54
栏目:
临床研究
出版日期:
2014-08-25

文章信息/Info

Title:
Clinical Observation of Xuefu Zhuyu Decoction Effect on Homocysteinemia of Coronary Artery Disease
作者:
李欣1马寿宏2
1. 上海中医药大学附属岳阳中西医结合医院,上海 200437;2. 通海县中医医院,云南通海 652700
Author(s):
LI Xin1 MA Shou-hong2
1.Yueyang Hospital of Integrated Troditional Chinese and Western Medicine, Shanghai University of TCM, Shanghai 200437, China 2. Tonghai Hospital of TCM, Tonghai 652700, China
关键词:
血府逐瘀汤 冠心病 高同型半胱氨酸血症 叶酸 中医药疗法
Keywords:
Xuefu Zhuyu decoction coronary artery disease hyperhomocysteinemia folic acid traditional Chinese medicine
分类号:
R256.22
DOI:
-
文献标识码:
A
摘要:
目的探讨血府逐瘀汤对冠心病伴高同型半胱氨酸(Hcy)血症患者的血清Hcy水平的影响。方法冠心病高同型半胱氨酸血症患者80例,随机分为叶酸组40例和血府逐瘀汤组40例,用药前后测定血浆Hcy水平。结果血府逐瘀汤组总有效率为95.0%,明显优于叶酸组的70%(P<0.05);叶酸组在西医常规治疗基础上,加予口服叶酸,随访3个月后Hcy水平较前下降,有统计学意义(P<0.05),血府逐瘀汤组在西医常规治疗的基础上,予以口服血府逐瘀汤,随访3个月后Hcy水平较前明显下降,有统计学意义(P<0.05),2组治疗后Hcy水平比较有统计学意义(P<0.05),血府逐瘀汤较之叶酸组有更为显著的下降(P<0.05)。结论血府逐瘀汤可明显降低冠心病高Hcy血症患者的血浆Hcy水平。
Abstract:
Objective To study the intervention function of Xuefu Zhuyu Decoction on the level of Hcy in plasma of coronary artery disease. Methods 80 patients with Hyperhomocysteinemia of coronary artery disease were divided into folic acid group(40 cases) and Xuefu Zhuyu Decoction group(40 cases)The levels of Hcy in plasma were determined before and after being treated. Results The total response rate in the Xuefu Zhuyu Decoction group was 95. 0%, which was significantly higher than 70. 0% in the folic acid group(P<0. 05). After being treated, the levels of Hcy in plasma in the folic acid group(40 cases)and Xuefu Zhuyu Decoction group decreased significantly(P<0. 05)。After the treatment in the three groups by analysis of variance was statistically significant(P<0. 05), Xuefu Zhuyu Decoction group than in the folic acid group were more obvious changes, there was statistical significance(P<0. 05). Conclusion Xuefu Zhuyu Decoction could obviously decrease the plasma Hcy levels in patients with coronary heart disease of high Hyperhomocysteinemia.

参考文献/References

[1] Boushcy CJ,Beresford SA,Omenn GS,et,al. A quantitative assessment of piasm a hom ocysteine as a risk factor for vascular disease probable benefit of increasing folic acid in takes[J]. JAMA,1995,274(13):1049-1057.
[2] Guo H,Lee JD,Xing Y,et al. Changes of homocysteine levels and arterial endothelia funcion in patients with high risk of coronary artery disease after 6-month folic acid supplemention[J]. Acta Cardiol,2004,59(5):503-506.
[3] 王洪巨,黄元伟,孙坚,等. 通心络胶囊对不稳定型心绞痛患者血管内皮功能的影响[J]. 中国中西医结合杂志,2003,23(8):587-589.
[4] Bostom AG,Selhub J. Homocysteine and arteriosclerosis:subclinical and clinical disease association[J]. Circulmion,1999,99(18):2361-2363.
[5] Omenn GS,Beresford SA,Motulsky AG. Preventing coronary heart disease:B vitamins and homocysteine[J]. Circulation,1998,97(5):421-424.
[6] Boushey CJ,Beresford SAA,Omenn GS,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes[J]. JAMA,1995,274(8):1049-1057.
[7] Bozkurt E,Keles S,Acikel M,et al. Plasma homocysteine level and the angiographic extent of coronary artery disease[J]. Angiology,2004,55(3):265-270.
[8] Mendis S,Ranatunga P. Hyperhamocyeteinsemia in Srilankan patient with coronary artery disease[J]. Ceylon Med J,2002,47(3):89-92.
[9] 肖正文. 血府逐瘀汤加减治疗冠心病心绞痛的临床疗效观察[J]. 中外医学研究,2012,10(1):2-3.

备注/Memo

备注/Memo:
基金项目: 玉溪市卫生局科研项目 收稿日期: 2014 - 04 - 29 作者简介: 李欣(1979-),女,安徽太和人,主治医师,研究方向:中西医结合防治老年心血管疾病,老年骨质疏松等。
更新日期/Last Update: 2014-08-20